DGX - Quest Diagnostics Incorporated
94.24 0.00 (0.00%)
After hours: 5:15PM EDT
| Previous Close | 93.08 |
| Open | 94.74 |
| Bid | 93.58 x 800 |
| Ask | 98.98 x 1100 |
| Day's Range | 93.23 - 94.89 |
| 52 Week Range | 78.95 - 116.49 |
| Volume | 1,289,900 |
| Avg. Volume | 1,346,125 |
| Market Cap | 12.683B |
| Beta (3Y Monthly) | 0.93 |
| PE Ratio (TTM) | 18.05 |
| EPS (TTM) | 5.22 |
| Earnings Date | Jul 22, 2019 - Jul 26, 2019 |
| Forward Dividend & Yield | 2.12 (2.36%) |
| Ex-Dividend Date | 2019-04-05 |
| 1y Target Est | 98.44 |
- ACCESSWIRE•yesterday
Key Healthcare Stocks To Watch as US Markets Approach Record Highs
CORAL GABLES, FL / ACCESSWIRE / April 24, 2019 / If there was one industry to be aware of right now, it's the healthcare industry. Definitive Healthcare's 2019 Annual Healthcare Trends Survey cited these two factors as major drivers to the future growth of the market. Today we are highlighting: Teladoc Health, Inc. (TDOC), TELUS Corporation (TU) (TSX:T.TO), Quest Diagnostics Incorporated (DGX), Premier Health Group (PHGRF) (PHGI.CN).
- Zacks•2 days ago
Quest Diagnostics (DGX) Jumps: Stock Rises 9.3%
Quest Diagnostics (DGX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
- Thomson Reuters StreetEvents•2 days ago
Edited Transcript of DGX earnings conference call or presentation 23-Apr-19 12:30pm GMT
Q1 2019 Quest Diagnostics Inc Earnings Call
- Motley Fool•2 days ago
Quest Diagnostics Beats Expectations in Q1
The diagnostics information services company provided an upside surprise on both the top and bottom lines.
- Investopedia•2 days ago
S&P 500 Flies Higher With Twitter
With Twitter stock soaring, the Nasdaq closed at a new high while the S&P 500 just missed, but trading volume was at extreme lows.
- Motley Fool•2 days ago
Why Quest Diagnostics Stock Jumped Today
A positive Q1 update provided a nice boost to the diagnostics information services stock.
- TheStreet.com•2 days ago
Quest Diagnostics Climbs on First-Quarter Earnings Beat
climbed 7.4% to $91.50 Tuesday after the diagnostic testing company reported better-than-expected first-quarter earnings. "We're off to a good start in 2019, with solid volume growth from our expanded health plan access," said Steve Rusckowski, chairman, president and CEO. "As we anticipated, volume accelerated through the quarter, and we look forward to continued progress as a member of UnitedHealthcare's Preferred Lab Network beginning July 1.
- Zacks•2 days ago
Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down
Quest Diagnostics (DGX) currently concentrates on its core diagnostic information services business and tries to maintain discipline in capital deployment.
- Associated Press•3 days ago
Quest Diagnostics: 1Q Earnings Snapshot
The Secaucus, New Jersey-based company said it had net income of $1.20 per share. Earnings, adjusted for one-time gains and costs, came to $1.40 per share. The results surpassed Wall Street expectations. ...
- PR Newswire•3 days ago
Quest Diagnostics Reports First Quarter 2019 Financial Results
- First quarter revenues of $1.89 billion , up 0.4% from 2018 - First quarter reported diluted EPS of $1.20 , down 5.4% from 2018; and adjusted diluted EPS of $1.40 , down 7.9% from 2018 - Cash provided ...
- Moody's•3 days ago
Quest Diagnostics Incorporated -- Moody's announces completion of a periodic review of ratings of Quest Diagnostics Incorporated
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Quest Diagnostics Incorporated and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
- PR Newswire•3 days ago
Forbes Names Quest Diagnostics One of America's Best Large Employers
Quest was among one of only fifteen companies in the Health Care Equipment and Services category to attain the designation. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
- Simply Wall St.•7 days ago
Are Investors Undervaluing Quest Diagnostics Incorporated (NYSE:DGX) By 34%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Quest Diagnostics Incorporated (NYSE:DGX) as an investment opportunity by taking the expected future cash flows and discounting them t...
- PR Newswire•8 days ago
Quest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™
SECAUCUS, N.J., April 18, 2019 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States. The new STD test packages are the first to be offered directly by Quest Diagnostics or any other major national laboratory to allow individuals to purchase tests at their discretion.
- Zacks•8 days ago
Can Five Elements Drive Quest Diagnostics (DGX) Q1 Earnings?
Quest Diagnostics (DGX) seems in sync with its strategy to expedite growth and operational excellence.
- Zacks•9 days ago
Quest Diagnostics (DGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool•11 days ago
Should We Blame Marijuana for a 14-Year High in Positive Work-Related Drug Tests?
Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.
- Investopedia•13 days ago
10 Stocks With Upside As Bull Rally Gets Pricey
These stocks, neglected by Wall Street, have the potential to post significant gains according to Jefferies.
- PR Newswire•15 days ago
Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories Increases in post-accident positivity in the general ...
- Markit•16 days ago
See what the IHS Markit Score report has to say about Quest Diagnostics Inc.
Quest Diagnostics Inc NYSE:DGXView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing * Economic output in this company's sector is expanding Bearish sentimentShort interest | NeutralShort interest is moderate for DGX with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on April 5. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding DGX is favorable, with net inflows of $27.79 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. DGX credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Insider Monkey•21 days ago
Here’s What Hedge Funds Think About Quest Diagnostics Incorporated (DGX)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]
- PR Newswire•21 days ago
Quest Diagnostics To Release First Quarter 2019 Financial Results On April 23
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-480-3547 for domestic callers or 203-369-1551 for international callers, no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on April 23, 2019 until midnight Eastern Time on May 7, 2019. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
- Simply Wall St.•21 days ago
Here's How P/E Ratios Can Help Us Understand Quest Diagnostics Incorporated (NYSE:DGX)
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We...
- PR Newswire•22 days ago
Quest Diagnostics Presents Supplier Excellence Awards to Four Partners
SECAUCUS, N.J. , April 3, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence awards to four companies ...
- Yahoo Finance Video•7 days ago
Checking in on trade war's impact on the markets
GuideStone Capital Management President David Spika joins Yahoo Finance's Adam Shapiro, Julie Hyman, Jared Blikre, and MIT Professor Sinan Aral.
